Insider and Institutional Ownership 91.5% of Syros Pharmaceuticals shares are owned by institutional investors. Comparatively, 50.1% of Vaccinex shares are owned by institutional investors. 12.3% of Syros Pharmaceuticals shares are owned by insiders. Comparatively, 51.5% of Vaccinex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge […]

Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) and CDT Equity (NASDAQ:CDT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability. Risk & Volatility Reviva Pharmaceuticals has a […]